Renovascular hypertension and ischemic nephropathy

American Journal of Hypertension

Volumn 23, Issue 11, 2010, Pages 1159-1169

  Textor, Stephen C ^a   Lerman, Lilach ^a  

^a MAYO CLINIC   (United States)

Author keywords

angioplasty; atheroemboli; blood pressure; BOLD MR; hypertension; renal artery stenosis; renin; renovascular hypertension; stent

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; ATHEROSCLEROTIC RENAL ARTERY STENOSIS; CARDIOVASCULAR RISK; COMPUTER ASSISTED TOMOGRAPHY; DOPPLER ECHOGRAPHY; HISTOPATHOLOGY; HUMAN; KIDNEY ARTERY STENOSIS; KIDNEY FUNCTION; KIDNEY INFARCTION; KIDNEY ISCHEMIA; MAGNETIC RESONANCE ANGIOGRAPHY; MUSCLE DISEASE; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; RENAL ARTERY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENOVASCULAR HYPERTENSION; REVASCULARIZATION; REVIEW; STENT;

HUMANS; HYPERTENSION, RENAL; ISCHEMIA; KIDNEY; RENAL CIRCULATION;

EID: 77958101209     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1038/ajh.2010.174     Document Type: Review

References (91)

1. The ASTRAL Investigators. Revascularization versus medical therapy for renal-artery stenosis. N Engl J Med 2009; 361:1953-1962.
2. Bax L, Woittiez AJ, Kouwenberg HJ, Mali WP, Buskens E, Beek FJ, Braam B, Huysmans FT, Schultze Kool LJ, Rutten MJ, Doorenbos CJ, Aarts JC, Rabelink TJ, Plouin PF, Raynaud A, van Montfrans GA, Reekers JA, van den Meiracker AH, Pattynama PM, van de Ven PJ, Vroegindeweij D, Kroon AA, de Haan MW, Postma CT, Beutler JJ. Stent placement in patients with atherosclerotic rena artery stenosis and impaired renal function: a randomized trial. Ann Intern Med 2009; 150:840-8, W150.
3. Mann SJ, Sos TA. Misleading results of randomized trials: the example of rena artery stenting J Clin Hypertens (Greenwich) 2010; 12:1-2.
4. Lorenz EC, Vrtiska TJ, Lieske JC, Dillon JJ, Stegall MD, Li X, Bergstralh EJ, Rule AD. Prevalence of renal artery and kidney abnormalities by computed tomography among healthy adults. Clin J Am Soc Nephrol 2010; 5:431-438.
5. Slovut DP, Olin JW. Fibromuscular dysplasia. N Engl J Med 2004; 350:1862-1871.
6. Hansen KJ, Edwards MS, Craven TE, Cherr GS, Jackson SA, Appel RG, Burke GL, Dean RH. Prevalence of renovascular disease in the elderly: a population-based study. J Vasc Surg 2002; 36:443-451.
7. de Mast Q, Beutler JJ. The prevalence of atherosclerotic renal artery stenosis in risk groups: a systematic literature review J Hypertens 2009; 27:1333-1340.
8. Krämer SC, Seifarth H, Pamler R, Fleiter T, Bühring J, Sunder-Plassmann L, Brambs HJ, Görich J. Renal infarction following endovascular aortic aneurysm repair: incidence and clinical consequences. J Endovasc Ther 2002; 9:98-102.
9. Loesch J. Ein Beitrag zur experimentellen Nephritis und zum arteriellen Hochdruck I. Die Veranderungen im Blutdruck II. Die Veranderungen in der Blutchemie. Zentralblatt fur Innere Medizin 1933; 7:144-169.
10. Goldblatt H, Lynch J, Hanzal RF, Summerville WW. Studies on experimenta hypertension: I. The production of persistent elevation of systolic blood pressure by means of renal ischemia J Exp Med 1934; 59:347-379.
11. Romero JC, Feldstein AE, Rodriguez-Porcel MG, Cases-Amenos A. New insights nto the pathophysiology of renovascular hypertension. Mayo Clin Proc 1997; 72:251-260.
12. Brunner HR, Kirshman JD, Sealey JE, Laragh JH. Hypertension of renal origin: evidence for two different mechanisms. Science 1971; 174:1344-1346.
13. Brunner HR, Gavras H, Laragh JH. Angiotensin-II blockade in man by sar1-ala8-angiotensin I for understanding and treatment of high blood-pressure. Lancet 1973; 2:1045-1048.
14. DeForrest JM, Knappenberger RC, Antonaccio MJ, Ferrone RA, Creekmore JS. Angiotensin II is a necessary component for the development of hypertension in the two kidney, one clip rat. Am J Cardiol 1982; 49:1515-1517.
15. Cervenka L, Horácek V, Vanecková I, Hubácek JA, Oliverio MI, Coffman TM, Navar LG. Essential role of AT1A receptor in the development of 2K1C hypertension. Hypertension 2002; 40:735-741.
16. Crowley SD, Gurley SB, Oliverio MI, Pazmino AK, Griffiths R, Flannery PJ, Spurney RF, Kim HS, Smithies O, Le TH, Coffman TM. Distinct roles for the kidney and systemic tissues in blood pressure regulation by the renin-angiotensin system. J Clin Invest 2005; 115:1092-1099.
17. Lerman LO, Nath KA, Rodriguez-Porcel M, Krier JD, Schwartz RS, Napoli C, Romero JC. Increased oxidative stress in experimental renovascular hypertension. Hypertension 2001; 37:541-546.
18. De B, Manoharan G, Pme K, Madaric J, Bartunek J, Vanderheyden M, Heyndrickx GR. Assessment of renal artery stenosis everity by pressure gradient measurements. J Am Coll Cardiol 2006; 48:1851-1855.
19. Simon G. What is critical renal artery stenosis? Implications for treatment. Am J Hypertens 2000; 13:1189-1193.
20. Gloviczki ML, Glockner JF, Lerman LO, McKusick MA, Misra S, Grande JP, Textor SC. Preser ved oxygenation despite reduced blood flow in poststenotic kidneys in human atherosclerotic renal artery stenosis. Hypertension 2010; 55: 961-966.
21. Losito A, Fagugli RM, Zampi I, Parente B, de Rango P, Giordano G, Cao P. Comparison of target organ damage in renovascular and essential hypertension Am J Hypertens 1996; 9:1062-1067.
22. Edwards MS, Craven TE, Burke GL, Dean RH, Hansen KJ. Renovascular disease and the risk of adverse coronary events in the elderly: a prospective, population-based study. Arch Intern Med 2005; 165:207-213.
23. Murphy TP, Cooper CJ, Dworkin LD, Henrich WL, Rundback JH, Matsumoto AH, Jamerson KA, D'Agostino RB. The Cardiovascular Outcomes with Rena Atherosclerotic Lesions (CORAL) study: rationale and methods J Vasc Interv Radiol 2005; 16:1295-1300.
24. Johansson M, Herlitz H, Jensen G, Rundqvist B, Friberg P. Increased cardiovascular mortality in hypertensive patients with renal artery stenosis. Relation to sympathetic activation, renal function and treatment regimens. J Hypertens 1999; 17:1743-1750.
25. Miyajima E, Yamada Y, Yoshida Y, Matsukawa T, Shionoiri H, Tochikubo O, Ishii M. Muscle sympathetic nerve activity in renovascular hypertension and primary aldosteronism. Hypertension 1991; 17:1057-1062.
26. Chade AR, Rodriguez-Porce M, Grande JP, Zhu X, Sica V, Napoli C, Sawamura T, Textor SC, Lerman A, Lerman LO. Mechanisms of renal structural alterations in combined hypercholesterolemia and renal artery stenosis. Arterioscler Thromb Vasc Biol 2003; 23:1295-1301.
27. Feltrin GP, Rossi G, Talenti E, Pessina AC, Miotto D, Thiene G, Da Palù C. Prognostic value of nephrography in atherosclerotic occlusion of the rena artery. Hypertension 1986; 8:962-964.
28. Zhu XY, Chade AR, Rodriguez-Porcel M, Bentley MD, Ritman EL, Lerman A, Lerman LO. Cortical microvascular remodeling in the stenotic kidney: role of ncreased oxidative stress. Arterioscler Thromb Vasc Biol 2004; 24:1854-1859.
29. Cheng J, Zhou W, Warner GM, Knudsen BE, Garovic VD, Gray CE, Lerman LO, Platt JL, Romero JC, Textor SC, Nath KA, Grande JP. Temporal analysis of signaling pathways activated in a murine model of two-kidney, one-clip hypertension. Am J Physiol Renal Physiol 2009; 297:F1055-F1068.
30. Lerman LO, Textor SC, Grande JP. Mechanisms of tissue injury in renal artery stenosis: ischemia and be og Cardiovasc Dis 2009; 52:196-203.
31. Chade AR, Rodriguez-Porande JP, Krier JD, Lerman A, Romero JC, Napoli C, Lerman LO. Distinct renal injury in early atherosclerosis and renovascular disease. Circulation 2002; 106:1165-1171.
32. Chade AR, Krier JD, Rodriguez-Porcel M, Breen JF, McKusick MA, Lerman A, Lerman LO. Comparison of acute and chronic antioxidant interventions in experimental renovascular disease. Am J Physiol Renal Physiol 2004; 286: F1079-F1086. (Pubitemid 38656363)
33. Keddis MT, Garovic VD. 38-year old woman with hypertension, headaches, and abdominal bruit. Mayo Clin Proc 2010; 85:674-677.
34. Cheung CM, Patel A, Shaheen N, Cain S, Eddington H, Hegarty J, Middleton RJ, Cowie A, Mamtora H, Kalra PA The effects of statins on the progression of atherosclerotic renovascular disease. Nephron Clin Pract 2007; 107:c35-c42.
35. Textor SC, McKusick MM, Misra S, Glockner J. Timing and selection for rena revascularization in an era of negative trials: what to do? Prog Cardiovasc Dis 2009; 52:220-228.
36. Silva VS, Martin LC, Franco RJ, Carvalho FC, Bregagnollo EA, Castro JH, Gavras I, Gavras H. Pleiotropic effects of statins may improve outcomes in atherosclerotic renovascular disease. Am J Hypertens 2008; 21:1163-1168.
37. Chade AR, Zhu X, Lavi R, Krier JD, Pislaru S, Simari RD, Napoli C, Lerman A, Lerman LO. Endothelial progenitor cells restore renal function in chronic experimental renovascular disease. Circulation 2009; 119:547-557.
38. Balk E, Raman G, Chung M, Ip S, Tatsioni A, Alonso A, Chew P, Gilbert SJ, Lau J. Effectiveness of management strategies for renal artery stenosis: a systematic review. Ann Intern Med 2006; 145:901-912.
39. Textor SC, Lerman L, McKusick M. The uncertain value of renal artery interv C Cardiovasc Interv 2009; 2:175-182.
40. Textor SC, Glockner JF, Lerman LO, Misra S, McKusick MA, Riederer SJ, Grande JP, Gomez SI, Romero JC The use of magnetic resonance to evaluate tissue oxygenation in renal artery stenosis J Am Soc Nephrol 2008; 19:780-788.
41. Napoli V, Pinto S, Bargellini I, Vignali C, Cioni R, Petruzzi P, Salvetti A, Bartolozzi C. Duplex ultrasonographic study of the renal arteries before and after renal artery stenting. Eur Radiol 2002; 12:796-803.
42. Olin JW, Piedmonte MR, Young Jr, DeAnna S, Grubb M, Childs MB. The utility of duplex ultrasound scanning of the renal arteries for diagnosing significant rena artery stenosis. Ann Intern Med 1995; 122:833-838.
43. Postma CT, van Aalen J, de Boo T, Rosenbusch G, Thien T Doppler ultrasound scanning in the detection of renal artery stenosis in hypertensive patients. Br J Radiol 1992; 65:857-860.
44. Radermacher J, Chavan A, Bleck J, Vitzthum A, Stoess B, Gebel MJ, Galanski M, Koch KM, Haller H. Use of Doppler ultrasonography to predict the outcome of therapy for renal-artery stenosis. N Engl J Med 2001; 344:410-417.
45. Krumme B, Hollenbeck M. Doppler sonography in renal artery stenosis-does the Resistive ndex predict the success of intervention? Nephrol Dial Transplant 2007; 22:692-696.
46. Fisher JEE, Olin JW: Renal artery stenosis: Clinical evaluation. In Creager MA, Loscalzo J (eds), Vascular Medicine: A Companion to Braunwald's Heart Disease. Philadelphia, PA, 2006, pp. 335-347.
47. Gloc nal MR and CT angiography: current concepts. Abdom Imaging 2007; 32:407-420.
48. Schoolwerth AC, Sica DA, Ballermann BJ, Wilcox CS: Renal considerations in angiotensin converting enzyme inhibitor therapy. Circulation 2001; 104: 1985-1991.
49. Elliott WJ, Martin WB, Murphy MB. Comparison of two noninvasive screening tests for renovascular hypertension. Arch Intern Med 1993; 153:755-764.
50. Geyskes GG, Oei HY, Puylaert CB, Mees EJ. Renovascular hypertension identified by captopril-induced changes in the renogram. Hypertension 1987; 9:451-458.
51. Setaro JF, Saddler MC, Chen CC, Hoffer PB, Roer DA, Markowitz DM, Meier GH, Gusberg RJ, Black HR. Simplified captopril renography in diagnosis and treatment of renal artery stenosis. Hypertension 1991; 18:289-298.
52. Postma CT, van Oijen AH, Barentsz JO, de Boo T, Hoefnagels WH, Corstens FH, Thien T. The value of tests predicting renovascular hypertension in patients with renal artery stenosis treated by angioplasty. Arch Intern Med 1991; 151:1531-1535.
53. van Jaarsveld BC, Krijnen P, Derkx FH, Oei HY, Postma CT, Schalekamp MA. The place of renal scintigraphy in the diagnosis of renal artery stenosis. Fifteen years of clinical experience. Arch Intern Med 1997; 157:1226
54. Taylor A Functional testing: ACEI renography. Semin Nephrol 2000; 20:437-444.
55. Kane GC, Textor SC, Schirger A, Garovic VD. Revisiting the role of nephrectomy for advanced renovascular disease. Am J Med 2003; 114:729-735.
56. Safian RD, Madder RD. Refining the approach to renal artery revascularization. JACC Cardiovasc Interv 2009; 2:161-174.
57. Cooper CJ, Murphy TP, Matsumoto A, Steffes M, Cohen DJ, Jaff M, Kuntz R, Jamerson K, Reid D, Rosenfield K, Rundback J, D'Agostino R, Henrich W, Dworkin L Stent revascularization for the prevention of cardiovascular and rena events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. Am Heart J 2006; 152:59-66.
58. Textor SC Renovascular hypertension and ischemic nephropathy. In Brenner BM (ed), Brenner and Rector's: The Kidney, chapter 46. Philadelphia, PA, 2004, pp. 2065-2108.
59. Rossi GP, Cavallin M, Rizzoni D, Bova S, Mazzocchi G, Agabiti-Rosei E, Nussdorfer GG, Pessina AC Dual ACE and NEP inhibitor MDL-100,240 prevents and regresses severe angiotensin II-dependent hypertension partially through bradykinin type 2 receptor J Hypertens 2002; 20:1451-1459
60. Losito A, Gaburri M, Errico R, Parente B, Cao PG. Survival of patients with renovascular disease and ACE inhibition. Clin Nephrol 1999; 52:339-343
61. Hackam DG, Duong-Hua ML, Mamdani M, Li P, Tobe SW, Spence JD, Garg AX. Angiotensin inhibition in renovascular disease: a population-based cohort study. Am Heart J 2008; 156:549-555.
62. Mann JF, Gerstein HC, Pogue J, Bosch J, Yusuf S. Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial. Ann Intern Med 2001; 134:629-636.
63. Solomon SD, Pfeffer MA, McMurray JJ, Fowler R, Finn P, Levin B, Eagle C, Hawk E, Lechuga M, Zauber AG, Bertagnolli MM, Arber N, Wittes J; APC and PreSAP Tria nvestigators. Effect of celecoxib on cardiovascular events and blood pressure in two trials for the prevention of colorectal adenomas. Circulation 2006; 114: 1028-1035.
64. Hall JE, Guyton AC, Jackson TE, Coleman TG, Lohmeier TE, Trippodo NC Contro of glomerular filtration rate by renin-angiotensin system. Am J Physiol 1977; 233:F366-F372.
65. Textor SC Renal failure related to angiotensin-converting enzyme inhibitors. Semin Nephrol 1997; 17:67-76.
66. Bakris GL, Weir MR. Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern? Arch Intern Med 2000; 160:685-693.
67. Kaa PAH, Kausz AT, Gilbertson DT, Liu J, Chen SC, Ishani A, Collins AJ, Foley RN. Atherosclerotic renovascular disease in United States patients aged 67 years or older: risk factors, revascularization, and prognosis. Kidney Int 2005; 68: 293-301.
68. White CJ. Management of renal artery stenosis: the case for intervention, defending current guidelines, and screening (drive-by) renal angiography at the time of catheterization. Prog Cardiovasc Dis 2009; 52:229-237.
69. Birrer M, Do DD, Mahler F, Triller J, Baumgartner I. Treatment of renal artery fibromuscular dysplasia with balloon angioplasty: a prospective follow-up study Eur J Vasc Endovasc Surg 2002; 23:146-152.
70. Stanley JC David M. Hume memorial lecture. Surgical treatment of renovascular hypertension. Am J Surg 1997; 174:102-110.
71. Novick AC Long-term results of surgical revascularization for renal artery disease. Urol Clin North Am 2001; 28:827-831, x
72. Balzer KM, Pfeiffer T, Rossbach S, Voiculescu A, Mödder U, Godehardt E, Sandmann W. Prospective randomized trial of operative vs interventiona treatment for renal artery ostial occlusive disease (RAOOD) J Vasc Surg 2009; 49:667-674; discussion 674.
73. Bloch MJ, Pickering T. Renal vascular disease: medical management, angioplasty, and stenting. Semin Nephrol 2000; 20:474-488.
74. sles CG, Robertson S, H ill D. Management of renovascular disease: a review of renal artery stenting in ten studies. 1999; 92:159-167.
75. Main J. The problem with ASTRAL J Renovascular Dis 2002; 1:19-23.
76. Nordmann AJ, Woo K, Parkes R, Logan AG. Balloon angioplasty or medical therapy for hypertensive patients with atherosc erotic renal artery stenosis? A meta-analysis of randomized controlled trials. Am J Med 2003; 114:44-50.
77. Rocha-Singh K, Jaff MR, Rosenfield K; ASRE-2 Trial Investigators. Evaluation of the safety and effectiveness of renal artery stenting after unsuccessful balloon angioplasty: the ASPIRE-2 study J Am Coll Cardiol 2005; 46:776-783.
78. Zeller T, Rastan A, Rothenpieler U, Müller C. Restenosis after stenting of atherosclerotic renal artery stenosis: is there a rationale for the use of drug-eluting stents? Catheter Cardiovasc Interv 2006; 68:125-130.
79. Topol EJ, Yadav JS. Recognition of the importance of embolization in atherosclerotic vascular disease. Circulation 2000; 101:570-580.
80. Modi KS, Rao VK. Atheroembolic renal disease. J Am Soc Nephrol 2001; 12: 1781-1787.
81. Hiramoto J, Hansen KJ, Pan XM, Edwards MS, Sawhney R, Rapp JH. Atheroemboli during renal artery angioplasty: an ex vivo study. J Vasc Surg 2005; 41:1026-1030.
82. Scolari F, Ravani P, Pola A, Guerini S, Zubani R, Movilli E, Savoldi S, Malberti F Maiorca R. Predictors of renal and patient outcomes in atheroembolic rena disease: a prospective study J Am Soc Nephrol 2003; 14:1584-1590.
83. Cooper CJ, Haller ST, Colyer W, Steffes M, Burket MW, Thomas WJ, Safian R, Reddy B, Brewster P, Ankenbrandt MA, Virmani R, Dippel E, Rocha-Singh K, Murphy TP, Kennedy DJ, Shapiro JI, D'Agostino RD, Pencina MJ, Khuder S. Embolic protection and platelet inhibition during renal artery stenting. Circulation 2008; 117: 2752-2760.
84. Chade AR, Mushin OP, Zhu X, Rodriguez-Porcel M, Grande JP, Textor SC, Lerman A, Lerman LO. Pathways of renal fibrosis and modulation of matrix turnover in experimental hypercholesterolemia. Hypertension 2005; 46:772-779.
85. Lerman LO, Chade AR. Angiogenesis in the kidney: a new therapeutic target? Curr Opin Nephrol Hypertens 2009; 18:160-165.
86. Textor SC Renovascular hypertension and ischemic nephropathy. In Brenner BM (ed), Brenner and Rector's: The Kidney, chapter 43. Philadelphia, PA, 2008, pp. 1528-1566.
87. Bax L, Mali WP Buskens E, Koomans HA, Beutler JJ, Braam B, Beek FJ, Rabelink TJ, Postma CT, Huysmans FT, Deinum J, Thien T, Schultze Kool LJ, Woittiez AJ, Kouwenberg JJ, van den Meiracker AH, Pattynama PM, van de Ven PJ, Vroegindeweij D, Doorenbos CJ, Aarts JC, Kroon AA, de Leeuw PW, de Haan MW, van Engelshoven JM, Rutten MJ, van Montfans GA, Reekers JA, Plouin PF, La Batide Alanore A, Azizi M, Raynaud A, Harden PN, Cowling M; STAR Study Group. The benefit of STent placement and blood pressure and lipid-lowering for the prevention of progression of renal dysfunction caused by Atherosclerotic ostia stenosis of the Renal artery. The STAR-study: rationale and study design. J Nephrol 2003; 16:807-812.
88. Uzzo RG, Novick AC, Goormastic M, Mascha E, Pohl M. Medical versus surgica management of atherosclerotic renal artery stenosis. Transplant Proc 2002; 34:723-725.
89. van Jaarsveld BC, Krijnen P, Pieterman H, Derkx FH, Deinum J, Postma CT, Dees A, Woittiez AJ, Bartelink AK, Man in't Veld AJ, Schalekamp MA. The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. Dutch Renal Artery Stenosis ntervention Cooperative Study Group. N Engl J Med 2000; 342:1007-1014.
90. Plouin PF, Chatellier G, Darné B, Raynaud A. Blood pressure outcome of angioplasty n atherosclerotic renal artery stenosis: a randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Hyper tension 1998; 31: 823-829.
91. Webster J, Marshall F, Abdalla M, Dominiczak A, Edwards R, Isles CG, Loose H, Main J, Padfield P, Russell IT, Walker B, Watson M, Wilkinson R. Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group J Hum Hyper tens 1998; 12:329-335.